Skip to main navigation

Client nav

About Arcturus
RNA Medicines
Technologies
Pipeline
Platforms
Business Development
Publications
Investor Relations

Media Coverage

Arcturus Therapeutics Nasdaq Tower 2nd Anniversary 1.9 MB
November 16, 2019
How to Invest in MRNA Technology
August 30, 2019
Arcturus Surges Ahead in the mRNA Market, Regaining 100% Rights to OTC Deficien…
February 11, 2019
Arcturus Therapeutics Nasdaq Tower 1st Anniversary 2 MB
November 16, 2018
JLABS Impact Report 2018
October 26, 2018
Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Comm…
November 16, 2017
Pictures by Ernst and Young (Finalists for the Entrepreneur Of The Year 2017 Aw…
August 23, 2017
Arcturus Therapeutics in the list of Cystic Fibrosis Key Companies
August 9, 2017
Arcturus Therapeutics Inc. is Listed in the Key Players List; Involved in Non A…
July 13, 2017
The Korea Herald News on Arcturus Therapeutics Inc.
July 7, 2017

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Next page next ›
  • Last page last »
Displaying 21 - 30 of 73
Arcturus-Covid19 Message.jpg

 

Nasdaq combined

Investor Home

Corporate Governance

  • Governance Highlights
  • Management Team
  • Board of Directors
  • Committee Composition

Financials & Filings

  • SEC Filings
  • Annual Reports
  • Quarterly Results

News & Events

  • Press Releases
  • Videos
  • Media Coverage
  • Presentations
  • Events

Stock Information

  • Stock Quote
  • Historical Price Lookup
  • Analyst Coverage

Investor Resources

  • Investor FAQ
  • Contact IR
  • Email Alerts
  • Home
  • Contact
  • Careers
  • Legal

© 2021 Arcturus Therapeutics, Inc.